Clinical Trials

BreastGastrointestinalLymphoidPlasma cell

Cytokine Release Syndrome, Burkitt Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT07457112 2026-03-09

EHCancer

Phase NA Completed

212 enrolled

Breast Neoplasms, Colonic Neoplasms, Lymphoma, Multiple Myeloma, Neoplasms

NCT07451743 2026-03-05

ACL ALL

Phase NA Not yet recruiting

100 enrolled

Anterior Cruciate Ligament Injuries, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05340686 2026-02-10

Braining- Aerobic Physical Activity as Add on Treatment in Bipolar Depression

Phase NA Suspended

54 enrolled

Bipolar Disorder, Lymphoma, Follicular, Motor Activity

NCT06114498 2026-01-23

Hospital Register of Decompensated Heart Failure With Preserved Ejection Fraction

Active not recruiting

240 enrolled

LymphoidOther

Lymphoma, Follicular, Obesity

NCT07211048 2026-01-21

Anti CD19 Gene Therapy for B-cell Lymphoma

18 enrolled

Lymphoma, B-Cell

NCT07135466 2026-01-16

A Phase 1/2 Study of T-cell Expressing an Anti-CD22 Chimeric-Antigen Receptor (SHB-04-CD22) in Patients With CD22-expressing B-cell Malignancies

Phase 1/2 Recruiting

50 enrolled

Leukemia, Lymphoma

NCT06421948 2025-12-05

Linperlisib Combined With Chidamide in Patients With PTCL

Phase 1/2 Recruiting

134 enrolled

Lymphoma, T-Cell, Peripheral

NCT06520163 2025-12-04

Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma

Phase 3 Recruiting

99 enrolled

Lymphoma, Non-Hodgkin

NCT05083208 2025-12-02

PI3Kδ Inhibitor Parsaclisib Combined With Chidamide for the Treatment of Relapsed/Refractory Peripheral T-cell Lymphoma

Phase 1 Terminated

12 enrolled

Lymphoma, T-Cell, Peripheral

NCT07258043 2025-12-02

EPOCH

Recruiting

45 enrolled

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04214626 2025-11-19

R-CHOP Combined With Lenalidomide in the First-line Treatment for Patients With Diffuse Large B Cell Lymphoma

Phase 2 Completed

60 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT07233720 2025-11-18

Zanubrutinib Combined With Rituximab in the Treatment for Patients With Marginal Zone Lymphoma

Recruiting

30 enrolled

Lymphoma, B-Cell, Marginal Zone

NCT06409767 2025-09-24

ALHERT

LymphoidOther hematologic neoplasmPlasma cell

2,224 enrolled

Leukemia, Lymphoma, Multiple Myeloma

NCT07191249 2025-09-24

A Phase 2, Multicenter, Open-Label Trial to Evaluate Efficacy and Safety of Subcutaneous (SC) Mosunetuzumab in Previously Untreated Low Tumor Burden Follicular Lymphoma (LTB-FL).

Phase 2 Not yet recruiting

30 enrolled

Phase NA Active not recruiting

Lymphoma, Follicular

NCT06026046 2025-09-19

EscrimHEMA

80 enrolled

Leukemia, Lymphoma

NCT07176130 2025-09-16

Demographics and Clinical Characteristics of Ocular Inflammatory Diseases in Singapore

Active not recruiting

200 enrolled

Endophthalmitis, Uveitis, Scleritis, Intraocular Lymphoma

NCT06832683 2025-09-10

Efficacy of Propofol-Ketamine and Sevoflurane in Children Undergoing Magnetic Resonance Imaging

Phase NA Completed

230 enrolled

Phase 1/2 Not yet recruiting

Hypoxia, Lymphoma, Follicular

NCT07162571 2025-09-09

MSTH-CAR002

17 enrolled

Lymphoma, B-Cell

NCT07134504 2025-08-21

Primary Prostatic Lymphoma on a 66 Year-old Male in Mexico.

LymphoidMyeloidPlasma cell

1 enrolled

GenitourinaryLymphoid

Lymphoma, Prostatic Neoplasms

NCT06944119 2025-07-28

Assesment of the Immune Response to RSV Vaccine in Patients With Myeloma, Lymphoma and Hematological Leukemia

Active not recruiting

250 enrolled

Lymphoma, Myelodysplastic Syndromes, Neoplasms, Plasma Cell

NCT06793410 2025-06-05

Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation

Phase 2 Recruiting

100 enrolled

LymphoidMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Lymphoma, Large B-Cell, Diffuse, Papillomavirus Infections

NCT06961669 2025-05-29

ECAR01

LymphoidOther hematologic neoplasmPlasma cell

18 enrolled

Multiple Myeloma, Recurrence, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06964841 2025-05-09

PRIMARY TESTICULAR LYMPHOMA

1 enrolled

Lymphoma

NCT04668365 2025-04-25

Zanubrutinib Combined With Standard Chemotherapy in the Treatment for Patients With Diffuse Large B Cell Lymphoma

Phase 2 Suspended

59 enrolled

Congenital Abnormalities, Lymphoma, Large B-Cell, Diffuse

NCT04263935 2025-04-23

Correlation Between Driver Gene Abnormalities and Clinicopathological Characteristics and Disease Prognosis in Lymphoma

Recruiting

200 enrolled

Lymphoma

NCT02964858 2025-04-11

DOBL

840 enrolled

Phase 2 Enrolling by invitation

Lymphoma, Non-Hodgkin

NCT06560879 2025-03-14

Effectiveness of Probiotics for the Prevention of Gastrointestinal Toxicity in Children With Leukemia

120 enrolled

GastrointestinalLymphoidOther hematologic neoplasm

Gastrointestinal Diseases, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06299462 2025-02-25

PTCy and ATG for MSD and MUD Transplants

Phase 1/2 Recruiting

50 enrolled

LymphoidMyeloidOther hematologic neoplasm

Graft vs Host Disease, Hodgkin Disease, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06798428 2025-01-29

For Grade I and II Knee Meniscal Injuries Patients ,Glucosamine, Chondroitin and Some Herbs Extract Phonophoresis Will Be Used (A) Versus Placebo(B)

Phase NA Completed

45 enrolled

Phase 4 Not yet recruiting

Lymphoma, Follicular

NCT06665737 2025-01-28

G-CSF in NHL

126 enrolled

Classical hematologyLymphoid

Lymphoma, Non-Hodgkin, Febrile Neutropenia

NCT06307600 2025-01-23

The Safety and Efficacy of RD06-03 CART Cell Injection in Patients With R/R Acute B-lymphoblastic Leukemia

Phase EARLY_PHASE1 Recruiting

9 enrolled

LymphoidOther hematologic neoplasmPlasma cell

Lymphoma

NCT06758713 2025-01-06

Safety and Efficacy of Fourth-Generation CAR-T in the Treatment of Hematologic Malignancies

Phase 1 Recruiting

60 enrolled

Multiple Myeloma, Lymphoma, B-Cell, Hematologic Neoplasms

NCT04637113 2024-11-07

SHACK

300 enrolled

Phase EARLY_PHASE1 Active not recruiting

Critical Illness, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03244176 2024-07-30

AvR-CHOP

28 enrolled

Phase 1 Active not recruiting

Lymphoma, B-Cell

NCT03245021 2024-07-30

1stFLOR

39 enrolled

Lymphoma, Follicular

NCT04311216 2024-07-22

Shoulder Instability in Children: Muscle Activity and Movement

30 enrolled 6 charts

Phase 3 Not yet recruiting

Shoulder Injuries, Joint Instability, Shoulder Dislocation, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06510530 2024-07-19

Astragalus for Symptomatic Alleviation in High-grade Lymphoma

60 enrolled

Lymphoma, Non-Hodgkin

NCT03346096 2024-07-09

TEAM

Phase 2 Completed

50 enrolled

Lymphoma

NCT06478381 2024-06-27

L218CAR19 in Patients With Relapsed/Refractory B-cell Lymphoma

Phase 1 Recruiting

22 enrolled

Phase 2 Not yet recruiting

Lymphoma, B-Cell

NCT06427213 2024-05-23

This is a Phase II, Open-label, Multicentre Study of Zanubrutinib-containing Regimens in Patients With Newly Diagnosed Mantle Cell Lymphoma

41 enrolled